QHSLab, Inc.

USAQ ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $38.0K $-103.9K $556.6K $33.4K $-53.0K $-79.6K $-287.6K $49.8K
Depreciation & Amortization $18.0K $18.0K $18.0K $18.0K $18.0K $36.6K $73.9K $18.0K
Depreciation — — — — — — — —
Amortization — $18.0K $18.0K $18.0K $18.0K $18.0K $18.0K $18.0K
Stock-Based Compensation $0 $0 $0 $0 $0 $0 $0 $0
Net Cash from Operating Activities $-7.8K $-200.2K $98.0K $2.6K $127.0K $-49.5K $55.1K $-56.6K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-36.9K $-73.8K $379.7K $-12.6K $-19.7K $-46.6K $6.2K $48.3K
Net Change in Cash $-44.7K $-274.1K $477.8K $-10.0K $107.3K $-96.1K $61.2K $-8.3K
Free Cash Flow — — — — — — — —
← Newer Page 1 of 6 Older →